81.89
-1.09 (-1.31%)
| Penutupan Terdahulu | 82.98 |
| Buka | 83.65 |
| Jumlah Dagangan | 682,477 |
| Purata Dagangan (3B) | 1,074,585 |
| Modal Pasaran | 14,203,620,352 |
| Harga / Pendapatan (P/E TTM) | 9.40 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.50 |
| Harga / Jualan (P/S) | 1.73 |
| Harga / Buku (P/B) | 2.89 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 4.56% |
| Margin Operasi (TTM) | 7.73% |
| EPS Cair (TTM) | 2.17 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -42.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 242.58% |
| Nisbah Semasa (MRQ) | 1.19 |
| Aliran Tunai Operasi (OCF TTM) | 772.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.05 B |
| Pulangan Atas Aset (ROA TTM) | 3.72% |
| Pulangan Atas Ekuiti (ROE TTM) | 10.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Solventum Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.5 |
| Purata | 0.88 |
|
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 20.00% |
| % Dimiliki oleh Institusi | 67.75% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Independent Franchise Partners Llp | 30 Sep 2025 | 12,899,240 |
| Trian Fund Management, L.P. | 30 Sep 2025 | 8,462,819 |
| Madison Avenue Partners, Lp | 30 Sep 2025 | 1,988,376 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 100.00 (BTIG, 22.12%) | Beli |
| Median | 98.00 (19.67%) | |
| Rendah | 79.00 (UBS, -3.53%) | Pegang |
| Purata | 92.33 (12.75%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 76.30 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 02 Dec 2025 | 100.00 (22.12%) | Beli | 85.59 |
| UBS | 10 Nov 2025 | 79.00 (-3.53%) | Pegang | 71.79 |
| 01 Oct 2025 | 77.00 (-5.97%) | Pegang | 73.04 | |
| Piper Sandler | 07 Nov 2025 | 98.00 (19.67%) | Beli | 71.52 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 25 Nov 2025 | Pengumuman | Solventum to Participate in the 2025 Piper Sandler Healthcare Conference |
| 20 Nov 2025 | Pengumuman | Solventum Announces $1 Billion Share Repurchase Program |
| 20 Nov 2025 | Pengumuman | Solventum Announces Agreement to Acquire Acera Surgical |
| 06 Nov 2025 | Pengumuman | Solventum Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | Pengumuman | Solventum to Participate in the 2025 Stifel Healthcare Conference |
| 21 Oct 2025 | Pengumuman | Solventum Appoints Heather Knight as Chief Commercial Officer |
| 16 Oct 2025 | Pengumuman | Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |